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The control of appetite in vertebrates is a complex process that depends on a range of signals 
from peripheral tissues and neuro- and endocrine signals originating in the brain. The 
hypothalamus is believed to be the main site for signal integration and control of appetite and 
feed intake. Previous studies on involvement of neuropeptides in appetite regulation in 
Atlantic salmon (Salmo salar) has been based on analysis of whole brain. No studies have 
involved dissection of the brain to quantify the spatial and temporal expression of the 
neuropeptides involved in appetite regulation in different parts of the brain.  
Neuropeptide Y (NPY), cocaine- amphetamine related transcript (CART), agouti-related 
protein 1 (AgRP-1) and proopiomelanocortin- a2s (POMCa2s) are neuropeptides believed to 
be involved in appetite regulation in Atlantic salmon. In the present study the mRNA 
concentration of these neuropeptides was assessed by qPCR in 6 parts of the brain. There was 
a significantly higher mRNA concentration of NPY in the forebrain compared to all the other 
tissues of the brain. POMCa2s showed a significant higher mRNA concentration in the 
pituitary than in all other parts of the brain. CART had a significantly higher expression in the 
forebrain than in cerebellum and pituitary while AgRP-1 showed no significant differences in 
mRNA concentration among the different brain tissues. As part of this study the fish went 
through a vaccination period that involved fasting, and the only significant differences found 
were in the forebrain for POMCa2s and in the midbrain for NPY. The extensive expression of 
neuropeptides involved in appetite control in different parts of the brain suggest other roles 
than appetite control for these neuropeptides, and/or the appetite control is being 
supplemented from other parts of the brain than the hypothalamus. This study shows that 
further research on the involvement of the neuropeptides in control of appetite cannot be 
based on analysis of whole brain and needs to focus on specific regions and signaling 




1 Introduction  
1.1 Background 
The aquaculture industry worldwide is rapidly increasing and in 2014 the amount of produced 
fish surpassed the wild fisheries in volume produced/caught annually. Aquaculture has the 
potential to continue to grow while the wild fisheries does not permit much additional 
sustainable growth based on the stocks currently exploited (FAO 2016, Gutierrez-Wing and 
Malone, 2006). In Norway the aquaculture industry is mainly focused on Atlantic salmon 
(Salmo salar) and to a small degree other species e.g. Rainbow trout (Oncorhynchus mykiss), 
Halibut (Hippoglossus hippoglossus) and cleaner fish used for salmon farming such as 
Lumpfish (Cyclopterus lumpus) and Ballan wrasse (Labrus bergylta). This thesis will 
however focus on salmon. As the Atlantic salmon is an anadromous species, the first period of 
the life cycle is in freshwater, and the latter part of its life in saltwater. This complicates the 
process of farming this species, as the fish needs to be successfully transferred from 
freshwater to saltwater after the smoltification. The salmon farming is a relatively new 
industry and has developed immensely since the start in the 1960s when some pioneer farmers 
started with one or a few small cages with a few hundred fish to supplement their income, to 
the present day billion-dollar industry with thousands of employees. During the 1970s a 
transformation took place in smolt rearing and development of dry feed for salmon, which 
contributed massively to the rapid expansion of the industry (Liu et al., 2011).  
  
With the expansion of the aquaculture industry many problems have arisen, such as different 
diseases and parasites as well as challenges with environmental impact. Many of the diseases 
that emerged as problems could be treated with vaccines from the early 90s, however 
parasites and in particular salmon lice (Lepeophteirus salmonis) have continued to be a huge 
problem for the industry. The salmon lice are costing the industry an enormous amount of 
resources and is in addition a problem for wild stocks of salmon (Costello et al., 2009). 
Keeping the salmon in sea cages for a shorter amount of time can be beneficial to reduce the 
probability of diseases and also salmon lice levels and reduce the time until salmon reaches 
slaughter weight (Kverneland, unpublished, 2018). One of the approaches to this is to produce 
larger smolts in Recirculating Aquaculture System (RAS) where the fish is kept in closed 




1.2 Recirculating Aquaculture Systems, RAS  
In a regular flow-through system the water will just flow through the facility and there is 
normally no need for oxygenating or apply methods to get rid of ammonia, CO2 and particles, 
given sufficient amount of water to the biomass. The water flow into the tank is the same as 
the flow at the outlet (Figure 1.1). This is in many ways the classical approach in smolt 
production, but in the later years RAS has become a more viable choice for many farmers 
with the increased knowledge and improvements in technology.  
 
Figure 1.1: The basic principle of a flow-through system. Water flows through the facility and 
is discharged out of the facility. The water is not recirculated and there will be no need to 
treat the water at the outlet (Ole Gabriel Kverneland, Akva Group).  
 
In a RAS facility the concept is to recirculate and rinse the water through an extensive water 
treatment and filter system which only require 1% fresh water, basically to dilute the 
concentration of NO3. This significantly conserve water and energy and is more economic and 
environmentally friendly, as well as reduce the risk of infectious pathogens (Gutierrez-Wing 
and Malone, 2006). If the water is not properly treated, a decline in water quality, with 
accumulation of CO2, NO2, NH4, NO3 and lower levels of oxygen will occur. Oxygen is 
pumped into the water to counteract the decline in oxygen in the tanks and also to prevent 
accumulation of CO2 by aeration. In mature and well-run RAS systems, the ammonia excreted 
from the salmon, will be converted to nitrite and nitrate in the biofilters. Good surveillance is 
important to keep control of all the factors regarding water quality. A schematic overview of a 






Figure 2.1: The basic principle of a RAS facility. This figure shows the inlet of new water 
being disinfected together with water coming from the tanks. A mechanical filter is used to 
remove particles from the water and some water is removed during this process as well. 
Buffer is added, and the water is sent through a biofilter, before it reaches the oxygen tank 
where oxygen is added, and the CO2 concentration is reduced. From there the water is 
pumped into the fish tanks before returning back to the inlet (Ole Gabriel Kverneland, Akva 
Group). 
 
To ensure an acceptable financial outcome the density of the fish needs to be kept high to 
produce as much fish as possible. This needs to be done without reducing the quality of the 
fish with regards to growth and fish health. With a high density of fish in the tanks, oxygen 
concentration decreases, and CO2 concentration increases. This needs to be adjusted with the 
addition of oxygen pumped into the water to counteract the loss of oxygen and the 
accumulation of CO2. A study on density in a RAS facility on sea bass (Dicentrarchus labrax) 
was conducted with densities of 10, 40, 70 and 100 kg m-3. No significant differences were 
observed between densities up to 70 kg m-3, however above this density the specific growth 
rate showed a reduction. This suggests an optimum density of 70 kg m-3 for farming sea bass 
in RAS (Sammouth et al., 2009). For Atlantic salmon densities of up to 62 kg m-3 did not 
show any significant differences in specific growth rate compared to lower densities 
(Kolarevic et al., 2014).  
 
The water conditions in RAS tanks can be kept stable all year (temperature, oxygen, CO2, 
NH4, NO2, and NO3) which gives the producer control and predictability and the production is 
not affected by season to the degree of a flow-through system. As 95-98% of the water is 
reused and harmful pathogens entering the facility can represent a potentially huge problem, 




ozone) to remove all potential harmful organisms. To remove any solids and large particles a 
mechanical filter is used to filtrate the water. This removes particulate debris from the water, 
but not small organic matter and nitrogen compounds. The biofilter converts ammonia and 
nitrite into less toxic nitrate. The biofilter consist of many plastic elements filled with 
nitrifying bacteria with a huge surface area (Lin et al., 2003).  
 
As part of the production period in the RAS facility salmon will undergo several stressful 
periods. These include, but are not limited to, transfer between tanks, sorting, vaccination and 
smoltification followed by adaption to salt water. When these periods are planned, the fish 
will also be fasted to reduce the metabolic stress. Consequently, these periods of stress and 
starvation should be kept as short as possible, to ensure good health and welfare to the fish. It 
is also important to understand how appetite is controlled and affected during periods of 
fasting, refeeding and stress. 
 
1.3 Appetite control 
Feed intake is controlled by centers in the brain. In vertebrates, the hypothalamus serves a key 
role in controlling appetite and ingestion of food and is also involved in control of allocation 
and growth (Rønnestad et al., 2017). Both endocrine and neuroendocrine signals reach the 
hypothalamus from other parts of the brain and also from peripheral organs such as the 
gastrointestinal tract (GI) and the liver. An area called the arcuate nucleus (ARC) in the 
hypothalamus is the primary part of the hypothalamus involved in regulating appetite. Two 
groups of peptides are produced in this area, 1; orexigenic neuropeptides (Neuropeptide Y 
(NPY) and Agouti-related peptide (AgRP)) and 2; anorexigenic neuropeptides (Cocaine and 
amphetamine regulated transcript (CART) and Pro-opiomelanocortin (POMC)) (Valassi et al., 
2008). Orexigenic factors stimulate the appetite, while anorexigenic factors inhibits appetite. 
For some of these peptides different isoforms have been discovered in Atlantic salmon e.g. 
four isoforms of POMC (-a1, -a2, -a2s and -b), (Valen et al., 2011, Murashita et al., 
2011).Other peptides involved in controlling food intake includes Orexins (OXs), Galanin 
(GAL), Melanin-concentrating hormone (MCH), corticotropin-releasing hormone (CRH), 
thyrotropin-releasing hormone (TRH) and neurotensin (NT) (Rønnestad et al., 2017, Wan et 
al., 2011). In this thesis NPY, CART, Agouti-related peptide-1 (AgRP-1) and Pro-
opiomelanocortin-a2s (POMCa2s) was selected for study because of their strong relationship 




Not much is known of how other parts of the brain than the hypothalamus contributes to 
appetite control in Atlantic salmon. Most of the studies that have been done so far on gene 
expression is based on analysis of the whole brain (Valen et al., 2011, Rønnestad et al., 2017). 
Studies done for cod larvae (Gadus morhua) suggest involvement in appetite regulation in 
both forebrain and midbrain by NPY and CART (Le et al., 2016). By dissecting the brain into 
different parts, the mRNA concentration in each tissue can be assessed. This will further 
expand our understanding of the interaction between different parts of the brain in the appetite 
regulation in Atlantic salmon.  
 
 
Figure 1.3: Key organs and signaling pathways believed to be involved in control of appetite 
in fish (Rønnestad et al., 2017).   
 
1.4 NPY 
NPY is apparently one of the strongest orexigenic neuropeptides in mammals (Valassi et al., 
2008, Rønnestad et al., 2017). However, in fish NPY seem to have variable impact on appetite 
in different species. In some species like Zebrafish (Danio rerio) and Rainbow trout, 
injections (into the third ventricle) of NPY results in an increase of short-term appetite 
(Yokobori et al., 2012, Aldegunde and Mancebo et al., 2006). In other species, among them 
Atlantic cod, NPY levels are elevated around the time of feeding, suggesting that NPY plays a 
role in short-term appetite increase (Kehoe and Volkoff, 2007). Another study on cod larvae 
showed high levels of NPY in the forebrain and the midbrain, suggesting that other parts of 
the brain is involved in appetite regulation. It is also suggested other functions of NPY from 








CART is a peptide with a strong anorexigenic effects in mammals (Valassi et al., 2008, 
Rønnestad et al., 2017). Multiple types of the CART gene have been discovered in different 
species e.g. rat and other mammals and birds in addition to fish species. Some fish species 
have multiple variants of CART, like goldfish (Carassius auratus) and zebrafish, but 
unexpectedly, only one version of the CART gene is found in salmon (Murashita et al., 2009, 
Valen et al., 2011). The mRNA expression of CART post-feeding has been shown to increase 
within 3h in salmon which is an indicator of an anorexigenic effect (Valen et al., 2011). 
Fasting for 6 days reduced the mRNA expression of CART in the brain further implicating an 
anorexigenic effect in salmon (Murashita et al., 2009).  CART is also believed to have other 




AgRP is also a strong orexigenic peptide together with NPY in mammals (Valassi et al., 2008, 
Rønnestad et al., 2017). This neuropeptide has been identified in several mammals, birds and 
a variety of different fish species. AgRP works as an antagonistic gene of the receptors MC3R 
and MC4R and participates in body weight regulation, appetite control and energy 
homeostasis. High mRNA expression of AgRP in both rats and zebrafish is correlated with 
obesity, which is a strong indicator of an orexigenic effect also in fish (Wan et al., 2012, 
Harrold et al., 1999). In common carp (Cyprinus carpio) AgRP-1 is strongly expressed in the 
brain, eye, testis, intestine, while AgRP-2 is only expressed strongly in the brain and the gills 
(Wan et al., 2012). In salmon two different isoforms of AgRP has been identified (AgRP-1 
and AgRP-2). AgRP-1 is highly expressed in the pituitary and the skin for the Atlantic 
salmon, while AgRP-2 is highly expressed in gonads, mid-gut and red muscle. Salmon 
starved for 6 days showed unexpectedly a decrease in mRNA expression for AgRP-1. This 
suggest a species-specific regulation of AgRP-1 and an anorexigenic effect for salmon 





POMC is an anorexigenic neuropeptide and a precursor peptide processed into different 
melanocortins which includes melanocyte-stimulating hormones (α-, β- and γ-MSH) and 
adrenocorticotropic hormone (ACTH) (Valassi et al., 2008, Rønnestad et al., 2017, Murashita 
et al., 2009). In mammals and birds only one gene of POMC is known, but in many fish 
multiple isoforms of POMC are present (Rønnestad et al., 2017). In salmon four isoforms of 
POMC (POMCa1, POMCa2, POMCa2s, POMCb) has been identified, mainly in the pituitary. 
POMCa1 and POMCb showed a short-term response after feed intake in Atlantic salmon. A 
study on salmon on the effect of fasting with regards to POMC showed reduced POMCa1 
expression after 6 days, and no significant difference with the other isoforms of POMC 
(Valen et al., 2011).  
 
1.8 Objective  
Currently there is little known of the location of the different neuropeptides in the different 
parts of the brain. Similar to other vertebrates, the appetite regulation for salmon is believed to 
be located in the ARC of the hypothalamus. This study is divided into two parts. The first part 
is to describe the mRNA expression of the four selected neuropeptides (NPY, CART, AgRP-1 
and POMCa2s) in different parts of the brain (forebrain, midbrain, cerebellum, hypothalamus, 
Saccus vasculosus and pituitary). The second part describes changes in the mRNA expression 
of the selected neuropeptides over two weeks with a period of fasting prior to vaccination and 
a recovery period until feeding is reestablished to normal levels.  
 
 
The following hypothesis were formulated for this experiment: 
H01a: NPY is only expressed in the hypothalamus. 
H01b: CART is only expressed in the hypothalamus. 
H01c: AgRP-1 is only expressed in the hypothalamus. 
H01d: POMCa2s is only expressed in the hypothalamus. 
H02: The mRNA expression of the different genes (NPY, CART, AgRP-1 and POMCa2s) in 
the different parts of the brain (forebrain, midbrain, cerebellum, hypothalamus, Saccus 





2 Materials and methods 
2.1 Hardingsmolt facilities  
The Hardingsmolt RAS facility is located on land in Tørvikbygd in Kvam municipality. 
Hardingsmolt was built in 2006 and was one of the first recirculating facilities in Norway. At 
Hardingsmolt 95-98% of the water is recycled, which leads to a much lower water 
consumption compared to a regular flow-through system. The total intake of water is 43200  
L h-1 from the Tørvikavatnet lake which lies in close proximity to the facility.  
 
2.2 Fish and rearing conditions 
2.2.1 Fish 
The Atlantic salmon used in this experiment were reared at Hardingsmolt AS. The eggs came 
from Salmobreed (Nystølen and Erfjord Stamfisk) (March 16th, 2017) and were incubated and 
hatched at the Hardingsmolt facility at ~5oC for approximately 500 degrees day (mean 
temperature times amount of days) following standard protocols. After hatching the 
temperature was slowly raised with 0.5oC to ~13oC (0.5 oC every other day), until the time of 
first feeding in May 2017.  
  
At first feeding (May 25th) the fish was transferred to 6m tanks (50m3) and kept for 3.5 
months (13oC) until an average body weight of ~15g. They were then transferred to 12m 
tanks (300m3) on September 8th. During the following period (September 8th to October 17th) 
the fish had continuous light, LL (light light). From October 18th to November 27th the light 
changed from LL to LD (light dark) 12:12. From November 28th the light was set back to LL.  
 
Temperature was kept at 13±1 oC which is considered the optimum temperature for salmon in 
this size range (Handeland et al., 2008). The dissolved oxygen levels ranged from 85-95% 
with a set-point at 90% (outlet water). The density of fish in the tank ranged from 25 kg m-3 to 
approximately 70 kg m-3 before transfer to the 16m tank.  
 
During the production cycle all water quality parameters (CO2 <15.0 mg L
-1; NO2 <0.5 mg   
L-1; NH4 <2 mg L
-1; NO3 <250 mg L
-1) and temperature were kept stable. This was monitored 




security. Dead fish were removed each day (1-80 individuals each day out of 250.000 fish in 
the experimental tank) to avoid diseases. The first day (November 16th) and the last days 
(November 24-30th) the fish was fed with commercial dry feed (Biomar CPK40). For the rest 
of the rearing period, the fish was fed commercial feed correlating to the size and temperature 
based on industry standards (Biomar, Norway). 
 
 
Figure 2.2: The large hall at Hardingsmolt facility with all the 12m tanks. The closest tank is 
empty at the time when the picture was taken. Bridges to walk on can be seen right over the 
tanks for the farmers to have an easy access to each of the tanks (Heima, 2016). 
  
2.2.2 Vaccination 
The fish were vaccinated following standard protocols for the plant. The fish was vaccinated 
with 1 PD (ALPHA JECT micro® 1 PD) and Micro 6 (ALPHA JECT micro® 6) at 
November 19th. The mortality was low (<0.1% day-1) during the time of the vaccination. A 
specialized team was hired to do the vaccination, which took several days to perform on all 
the tanks. The fish from the 12m tank was pumped to a sedation tank to be anesthetized. 
When the fish was sedated it was sent to a table were four people arranged the salmon facing 
the right way for the vaccination. Each of the salmon then got the vaccine with a syringe 




    
Figure 2.3: The left image shows the tank were the fish was sedated. This is a small tank, and 
not too many fish can be in this tank at the same time. This tank is closely monitored to keep 
oxygen and CO2 levels acceptable. The middle image shows the table were the fish was sorted 
for size and arranged correctly. The right image shows the salmon after vaccination being 





2.3 Experimental design 
The aim of the sampling design was to document responses in appetite controlling 
neuropeptides during a standard vaccination protocol. Sampling started with fed fish that was 
then fasted prior to vaccination, and then the group was followed until appetite and feed 
intake had resumed and reached normal levels for the size and temperature conditions used. 
There were all together seven samplings around the vaccination (November 16th – November 
30th); 2 samples before vaccination and 5 after vaccination (Figure 2.4).  
 
Pre-vaccination: Two samplings were taken before the vaccination, one control that was fed 
and with food in the GI tract (November 16th) and one group (N=8) sampled after three days 
of starvation (November 19th). 
 
Post-vaccination: 5 samplings were taken after the vaccination, four of these were starved 
fish (November 19th, November 20th, November 22nd and November 26th), while the last 
sampling was fed fish (November 30th).  
 
Figure 2.4: Schematic overview of the experiment with samples taken before and after the 




2.4 Sampling protocol 
A total of 8 fish was collected at each sampling. A hand dip net was used to collect fish 
randomly from the experimental tank. Only one fish was collected each time and then placed 
into a bucket with high concentration of Finquel vet. (100% metacain) to reduce the time from 
euthanasia until tissue collection to preserve the tissues as best as possible (Figure 2.5). The 
fish was measured in length and weight (Ohaus Valor 2000 and a length scale) (Figure 2.6). 
The whole brain was dissected out and put in RNA-later (SIGMA) in a Sterile 5ml Centrifuge 
Tube (Eppendorf®). The pituitary was removed separately and put in RNA-later in Axygen® 
1.5mL MaxyClear Microtubes. The samples were brought back to University of Bergen and 
stored in -80oC until dissection.   
      
Figure 2.5: Salmon in the bucket with high                       Figure 2.6: Weight and length scale. 







2.5 Dissection of the brain 
The brains of the salmons were thawed while still in RNA-later to protect the integrity of the 
RNA. Next, the brain was dissected into 5 different parts (Figure 2.7). The pituitary was 
already separated at sampling and proceeded to analysis without any further processing. The 
first cut isolated the forebrain which consists of the olfactory bulb and the telencephalon. The 
pineale gland (Epiphysis) were not present on all the samples (some were lost during the 
sampling). In order to standardize the forebrain, the pineale was therefore removed from all 
brains to avoid differences caused by the concentration of neuropeptides in the pineale. On a 
few test brains, the olfactory bulb was removed. However, this proved to be challenging since 
the cutting was not consistent on all fish. The olfactory bulb was then decided to be included, 
to get consistency between all the brain samples. The dissection cut was made from the dorsal 
side and downwards to the ventral side between the forebrain (Telencephalon) and the 
midbrain (Tectum opticum) on the same location on all brains.  
  
 
Figure 2.7: Schematic drawing of the salmon brain. The blue lines indicate location of the 
cuts that separated the brain into sections (Illustration by Tharmini Kalananthan, 2018). 
 
The next cut was made between the midbrain and the hindbrain (Cerebellum) and was also 
made from the dorsal side and downwards to the ventral side. Next, the medulla oblongata 




process (Figure 2.7). After this cut the brain was then turned around and the hypothalamus 
was removed with a cut from the anterior to the posterior side. Following, the Saccus 
vasculosus was cut off from the hypothalamus. This structure was easy to recognize due to its 
dark red color and was removed with as little extra tissue as possible. The remaining part 
consisted of the midbrain. The different parts of the brain were frozen in separate Eppendorf 
tubes at -80oC until RNA-extraction. 
 
2.6 RNA extraction  
RNA-extraction of the dissected brain samples was conducted using a protocol for RNA 
extraction with TRI reagent based on Chomczynski, (1993.). Centrifuge tubes (2 ml) were 
prepared with 0.6-0.7g Precellys® Zirconium Oxide Beads (1.4mm) using a balance 
(Sartorius BP 61S). Each tube was added 1 ml of TRIzol Reagent. The frozen tissue was 
added to the Eppendorf-tube after being squeezed on a paper to remove any leftover RNA-
later and left on ice-block for 5 minutes. The samples were subsequently homogenized using a 
Precellys 24 homogenizer for 15 seconds at 5000 RPM (rotations per minute). The 
homogenized samples were left at room temperature for 5 minutes for the foam to disperse, 
before adding 200µl chloroform (≥99.5%) and vortexing for 1 minute. The tubes were then 
placed in a centrifuge (5415 R) for 15 minutes at 4oC at 13.2 RCF (relative centrifugal force) 
while new Eppendorf tubes where prepared for the next phase. The tubes from the centrifuge 
had 3 layers, an aqueous phase on top, an interphase in the middle, and an organic phase at the 
bottom. The RNA is located in the aqueous phase, and this was carefully transferred with a 
pipette to the newly prepared Eppendorf tubes, while avoiding any white interphase. In the 
new tubes with the aqueous phase, 500µl of Isopropanol (≥99.5%) was added and left at room 
temperature for 10 minutes before the samples was put back in the centrifuge for 10 minutes 
at 4oC at 13.2 RCF. 
  
After this step, a little RNA-pellet could be observed as a white lump at the bottom of the 
Eppendorf tube in some of the samples, but some of the tissue had a too small starting 
concentration for this to be visible. This was the case for Saccus vasculosus and the pituitary 
for the most part, as these tissues were the smallest. With the RNA-pellet in the Eppendorf 
tube, the supernatant was decanted as best as possible, and 1ml 80% EtOH was added to the 




then the supernatant was removed carefully with a pipette and the RNA-pellet was left to dry 
for 5-10 minutes. The pellet was reconstituted in nuclease free water using 50µl for forebrain, 
midbrain, cerebellum and hypothalamus, and 15µl for Saccus vasculosus and the pituitary. 
This was based on the pellet size. The last step on this procedure was to precipitate RNA by 
adding 1/10 of the volume of the water with 3M NaAc, pH 5.2 and 2 time the volume of the 
water with -20oC 100% EtOH. This represented 5µl NaAc and 100µl 100% EtOH in the 
forebrain, midbrain, cerebellum and hypothalamus. In the Saccus vasculosus and the pituitary 
this came out to be 1.5µl NaAc and 30µl 100% EtOH. Then all samples were stored in -80oC 
freezer until cDNA synthesis.  
 
2.7 cDNA synthesis 
The RNA samples were transferred from -80oC to the centrifuge and spun for 30 minutes at 
4oC at 13.2 RCF. This was followed by decanting of the supernatant, flash spin and removing 
the last drop with a pipette. The pellet was then air dried for 5-10 minutes and then 
resuspended in nuclease free water again. The volume ranged from 10µl for the smallest 
tissue to 40µl in the largest tissue. The RNA was then quantified using NanoDrop 
Spectrophotometer (Thermo Scientific™ NanoDrop™).  
  
8µl of RNA at 125ng µl-1 concentration were used and added to 1µl of 10X ezDNase Buffer 
(SuperScript IV VILO™) and 1µl ezDNase enzyme (SuperScript™ IV VILO™) and then 
incubated (Applied Biosystems 2720 Thermal Cycler) at 37oC for 2 minutes to make gDNA. 
Mastermix was made using 4µl SuperScript™ IV VILO™ Master Mix and 6µl Nuclease-free 
water. 10µl of master mix was added to the 10µl of gDNA for a total of 20µl. A Negative RT 
was created adding 4µl of SuperScript™ IV VILO™ No RT Control and 6µl of nuclease-free 
water to 10µl of gDNA from a sample with high volume. This was mixed and incubated 
(Applied Biosystems 2720 Thermal Cycler) for 25oC for 10 minutes, 50oC for 10 minutes, 
and 85oC for 5 minutes. The result is cDNA with 50ng µl-1 concentration.  
  
A dilution was prepared using 15µl cDNA (50ng µl-1) and 22.5µl nuclease-free water 




Another dilution was made by taking 2µl of the previous dilution of 20ng µl-1 and adding 
78µl nuclease-free water, which gives 80µl of 0.5ng µl-1 cDNA. The two cDNA dilutions 
were stored at -20oC until further use in the quantitative polymerase chain reaction (qPCR).  
 
2.8 qPCR  
The qPCR, also known as real-time polymerase chain reaction (Real-time PCR) was used to 
quantify the expression of the target genes (NPY, CART, AgRP-1 and POMCa2s). CFX96™ 
Real-Time System (BIO-RAD) was used, coupled with the software Bio-Rad CFX manager 
(version 3.1) to perform the qPCR. For the qPCR a 96-plate well (BIO-RAD) was used. Each 
well consisted of 10µl iTaq™ Universal SYBR® Green Supermix, 0.6µl primer F (table 2.1), 
0.6µl primer R (table 2.1), and 6.8µl nuclease-free water. 2µl of cDNA with concentration 
20ng µl-1 was added in addition for a total of 20µl in each well, resulting in 40ng RNA per 
well. The protocol used for the qPCR was 95oC for 30 sec, then 40 cycles of 95oC for 5 sec 
and 60oC for 25 sec. All samples were run in duplicates to exclude pipetting errors. All plates 
also had a duplicate of NTC (non-template control) and NRT (No-reverse transcriptase 
control) to exclude genomic DNA contamination in the samples. The first plate on each gene 
had a standard dilution curve with 1:10 dilution (made from PCR products), and all plates had 
a cDNA pool used as BPC (between plate control) to correct for differences between the 
different plates. Ef1a was used as housekeeping gene to normalize the qPCR results on the 
gene expression analysis. Ef1a has previously demonstrated to be a stably expressed gene in 
salmon and used by the department laboratory as references for relative expression studies 












Table 2.1: Primer name and sequence used in this experiment 



































SsEF1 SYBR Fw 
SsEF1 SYBR Rv 
GAGAACCATTGAGAAGTTCGAGAAG 
GCACCCAGGCATACTTGAAAG 







2.9 Statistical analysis 
For the statistical analysis in this study the statistical program STATISTIKA 13.2 was used. 
All data sets fulfilled the requirements of normality, independence of individuals and 
homogeneity of variances to perform the ANOVA.  
To determine the level of significance for the mRNA expression in the different tissues 
(forebrain, midbrain, cerebellum, hypothalamus, Saccus vasculosus and pituitary) for each of 
the selected neuropeptides (NPY, CART, AgRP-1 and POMCa2s) a one-way ANOVA was 
conducted. For NPY, CART and POMCa2s a significant difference was observed from the 
one-way ANOVA and a post-hoc test was performed (Student-Newman-Keuls test) to 
identify the difference between the brain tissues.  
In addition, a one-way ANOVA was conducted for each part of the brain for each 
neuropeptide with regards to the different samplings. This was done to examine any 
differences between the samplings regarding each tissue and neuropeptide. A post-hoc test 
(Student-Newman-Keuls test) was performed when a significant difference was observed in 
the one-way ANOVA.   
One fish was removed from the second sampling (morning November 19th) due to values 
outside of normal. All statistical results are given in Appendix, table 1-35. Differences were 
considered significant when p<0.05. All data in figures are given as a mean ± standard error 







3.1 Weight and length 
The experiment lasted for two weeks and there were altogether seven sampling points. There 
were no significant differences in weight and length between the samplings (November 16th, 
19th in the morning, 19th in the afternoon, 20th, 22nd, 26th and 30th). The average body weight 
and length of all the fish in this experiment was 58.45 ± 1.60 g and 16.38 ± 0.15cm (n=56) 
(Figure 3.1 and 3.2). The average body weight (measured as part of the routine production 
protocol at Hardingsmolt) in the tank was 51.4g (November 20th). 
 
  
Figure 3.1: Weight (g) of the experimental    Figure 3.2: Length (cm) of the experimental fish 



































































3.2 Gene expression 
The brain was dissected into five sections + the pituitary. The expression of mRNA for each 
of the selected neuropeptides was quantified in each part.  
3.2.1 NPY relative expression 
There were significantly (p<0.05) higher mRNA expression of NPY in the forebrain than the 
other brain tissues (Figure 3.3). There were no significant differences between expressed 
mRNA levels of NPY in the other parts of the brain.  
 
Figure 3.3: Expressed mRNA levels of NPY, relative to the housekeeping gene (Ef1a) in the 
different brain tissues from the first sampling (November 16th, n=3). Different letters 
represent significant difference in mRNA expression between groups (p<0.05). Value 





3.2.2 CART relative expression 
There was a significant difference (p<0.05) in mRNA expression of CART between forebrain 
and cerebellum and between forebrain and pituitary (p<0.05) (Figure 3.4). There was no 
significant difference between forebrain and midbrain, forebrain and hypothalamus and 
forebrain and Saccus vasculosus. There was no significant difference between the other parts 




Figure 3.4: Expressed levels of CART, relative to the housekeeping gene (Ef1a) in different 






3.2.3 AgRP-1 relative expression 
There was no significant difference between any of the different tissues regarding the 
expressed mRNA for AgRP-1. The mean values of hypothalamus, Saccus vasculosus and 
pituitary (72.11, 75.81 and 85.95 times higher mRNA concentration than midbrain 
respectively) were higher than the mean value of forebrain, midbrain and cerebellum, but 
these differences were not significant (Figure 3.5). For hypothalamus and Saccus vasculosus 
the difference in CT value from the qPCR differ substantially between each fish, which is 
illustrated at the error bars. Only 3 fish from this sampling is used for the analysis which gives 
a greater variation.  
 
 
Figure 3.5: Expressed levels of AgRP-1, relative to the housekeeping gene (Ef1a) in different 





3.2.4 POMCa2s relative expression 
There was a significantly higher (p<0.05) level of mRNA expression of POMCa2s in pituitary 
compared to the other parts. Hypothalamus and Saccus vasculosus showed a higher average 
(8.56 and 7.05 times higher mRNA expression than the cerebellum respectively) mRNA 
expression than the forebrain, midbrain and cerebellum, however the difference was not 
significant (Figure 3.6).   
 
 
Figure 3.6: Expressed levels of POMCa2s, relative to the housekeeping gene (Ef1a) in 
different brain tissue of the first sampling (November 16th, n=3). Pituitary continues over the 





3.3 Changes in mRNA expression during the vaccination protocol 
3.3.1 Development of mRNA expression in Forebrain 
The mRNA expression of NPY, CART and AgRP-1 in the forebrain were not significant 
different between the samplings during the experiment. The expression of mRNA of 
POMCa2s showed significant higher (p<0.05) values in the first sampling (November 16th) 




Figure 3.7: The mRNA expression of NPY, CART, AgRP-1 and POMCa2s during the time of 
the experiment in the forebrain in relation to the housekeeping gene; EF1a. Different letters 
represent a significant difference (p<0.05) in mRNA expression. N=3, 4, 5, 4, 6, 4 and 5 



























































































































































3.3.2 Development of mRNA expression in Midbrain 
There was a significant difference (p<0.05) in mRNA expression for NPY in the forebrain 
between sampling 2 (November 19th) and 7 (November 30th). No significant differences were 
seen between the other samplings in regard to NPY. CART, AgRP-1 and POMCa2s showed 




Figure 3.8: The development of mRNA expression NPY, CART, AgRP-1 and POMCa2s 






















































































































































3.3.3 Development of mRNA expression in Cerebellum 
There was no significant difference in mRNA expression of NPY, CART, AgRP-1 and 
POMCa2s between the different samplings in cerebellum (Figure 3.9).  
   
  
  
Figure 3.9: The development of mRNA expression of NPY, CART, AgRP-1 and POMCa2s 






















































































































































3.3.4 Development of mRNA expression in Hypothalamus 
There was no significant difference (p>0.05) in mRNA expression of NPY, CART, AgRP-1 
and POMCa2s between the different sampling in hypothalamus (Figure 3.10).  




Figure 3.10: The development mRNA expression of NPY, CART, AgRP-1 and POMCa2s 





















































































































































3.3.5 Development of mRNA expression in Saccus vasculosus 
There was no significant difference in mRNA expression of NPY, CART, AgRP-1 and 
POMCa2s between the different samplings in Saccus vasculosus (Figure 3.11).  
 
                 
  
  
Figure 3.11: The development of mRNA expression of NPY, CART, AgRP-1 and POMCa2s 


















































































































































3.3.6 Development of mRNA expression in Pituitary 
There was no significant difference in mRNA expression of NPY, CART, AgRP-1 and 





Figure 3.12: The development of NPY, CART, AgRP-1 and POMCa2s during the time of the 






















































































































































4.1 Water parameters  
This experiment was conducted at a RAS facility with a high level of control of the water 
parameters including temperature, oxygen, CO2, NO2, NO3 and NH4. The production data 
from the facility shows that the water parameters was kept stable and at satisfactory levels 
during the whole experimental period (Appendix, table 35). Therefore, these factors did not 
affect the results for this experiment.  
 
4.2 Discussion of methods 
The sampling was conducted over two weeks at approximately 10 a.m. each time, except for 
one day with two samplings; November 19th, one sampling in the morning in fish before the 
vaccination and one in the afternoon after the vaccination. 8 fish were collected at each 
sampling and the tissues were brought back on RNA-later to Høyteknologisenteret in Bergen 
and stored in freezer at -80oC for further dissection and analysis in the laboratory. In the 
laboratory the brains were dissected, RNA was extracted from each part, cDNA was made, 
and qPCR were performed for each neuropeptide in addition to Ef1a as a reference gene. 
After the RNA extraction the quality of the RNA was quantified with the NanoDrop 
Spectrophotometer. From this quantification the problem with the low mRNA concentration 
in Saccus vasculosus and in the pituitary were encountered. Many of the samples had to be 
dismissed at this point. The reason for the low mRNA concentration was that the experimental 
fish was small (average weight 58.45 ± 1.60 g) which also corresponds to a small brain. This 
caused quite a few fish to have a very low mRNA concentration in the Saccus vasculosus and 
also in the pituitary. The mRNA concentration after RNA extraction was below 125ng µl-1 
and could not be used to create cDNA, since 125ng µl-1 is the required minimum to be able to 
make the cDNA concentration needed for this analysis. This was an unforeseen issue and 8 
fish from each sampling proved to be insufficient. Only 3 of 8 fish from the control group 
could be used for the analysis. 
 
POMCa2s showed a melting curve of poor quality with no single peak with regards to 
forebrain, midbrain and the cerebellum (Figure 4.1). For hypothalamus, Saccus vasculosus 




specificity of the primers (Figure 4.2). In an earlier study (Valen et al., 2011) the same 
primers were used successfully for POMCa2s, but that analysis was conducted with the whole 
brain, and not dissected into different parts. The primers for POMCa2s didn’t seem to be 
specific for the forebrain, midbrain and the cerebellum, but showed good results for the 
hypothalamus, Saccus vasculosus and the pituitary. Other qPCR tests run at this department 
with the same primers also confirmed the same problem with the forebrain, midbrain and 
cerebellum for POMCa1, POMCa2 and POMCb. New primers were designed to be more 
specific for the different isoforms of POMCa2s, but these could not be tested and validated in 
time for this thesis.  
 
Figure 4.1: Melting curve for POMCa2s for all tissues of the brain. Green straight line is the 






Figure 4.2: Melting curve for POMCa2s for hypothalamus, Saccus vasculosus and the 
pituitary. Green straight line is the threshold line for the CT value. The same 8 fish that is 
shown in figure 4.1 is present here, but forebrain, midbrain and cerebellum are not included. 
NRT and NTC is excluded as well.  
 
Another challenge for this experiment was the experimental design. From the first to second 
sampling (November 16th – 19th) the only effect taking place was starvation for 3 days, so 
differences in mRNA expression here can be accounted for as differences caused by 
starvation. For sampling three to six (November 19th, 20th, 22nd and 26th) the fish was both 
starved and stressed from vaccination. Two different parameters were deviant from normal 
conditions during these samplings. These different parameters (starvation and stress) have an 
opposite effect on the appetite and will work against each other. The last sampling consisted 
of vaccinated fish, but on this sampling the fish was fed. For the rest of the samplings there 
will be an uncertainty to what effect that will cause differences. Either starvation or stress can 
be contributing factors to a difference in mRNA expression.   
 
Low sample size increases the variance and standard error, and it will be harder to observe 
any significant differences. This is shown by large error bars in the results and many of the 
results are not significantly different. If this experiment is replicated, a larger sample size 
should be used, and larger fish collected to reduce the probability of too low mRNA 




the experiment should also be different, to only have starvation or stress as a factor. This will 
be a challenge to conduct during a vaccination protocol as the fish is starved as a standard 
protocol. To overcome this issue a study of the appetite can be conducted with a starvation 
period of two weeks to see the impact on the mRNA expression in each of the brain tissues. 
When the expression is known with the effect of starvation, the experiment can be duplicated 
with a vaccination protocol with the same starvation. This way the effect of the vaccination 
can be seen in relationship with the starvation effect.  
 
4.3 Discussion of results 
4.3.1 Spatial and temporal changes in NPY  
NPY has been identified as one of the most potent orexigenic peptides in mammals as well as 
other species (Valassi et al., 2008, Rønnestad et al., 2017). NPY seems to have variable roles 
in appetite control in different fish species. In a study on Atlantic salmon NPY did not affect 
short-term feeding to the extent it does in some other species e.g. cod and rainbow trout 
(Aldegunde and Mancebo, 2006, Kehoe and Volkoff, 2007, Murashita et al., 2009). In 
Chinook and Coho salmon (Oncorhynchus tshawytscha, Oncorhynchus kisutch) mRNA 
expression of NPY was shown to increase in hypothalamus during fasting which indicates an 
orexigenic effect (Silverstein et al., 1998). In Atlantic salmon however 6 days of fasting 
showed no significant expression of NPY in the brain (Murashita et al., 2009).  
NPY has different roles in addition to be a powerful enhancer of the appetite. These include 
physiological processes such as cardiovascular control, anxiety, sexual behavior and circadian 
rhythms (Dumont et al., 1992, Murashita et al., 2009). NPY has also been found in high 
concentration in the eye and also in the forebrain of the salmon. Since the primary center for 
the appetite regulation is the ARC in the hypothalamus, this suggest different roles for NPY in 
other regions of the brain (Murashita et al., 2009).  
 
For this experiment all the brains were dissected into 6 different parts, and the concentration 
of NPY was studied for all the different parts. Hypothalamus showed a low concentration 
(10.2%) of expressed mRNA compared to the forebrain. There was a significant higher 
(p<0.05) mRNA concentration in the forebrain than all the other parts of the brain. No other 
significant difference was found between other parts of the brain (Figure 3.3). The expressed 




but these differences are not significant. With a higher mRNA concentration in the forebrain 
than in the hypothalamus, this may suggest that NPY has other roles in this part of the brain or 
that feeding is also affected by pathways in the forebrain. In a study with cod larvae, NPY 
also had the highest expression in the forebrain (telencephalon), as well as in the midbrain (Le 
et al., 2016). This indicate some participation in appetite control by the forebrain previously 
not described in the salmon. With a higher sample size, the results may reveal significant 
differences between the other parts as well, but it still needs to be verified that the expression 
of NPY in this section responds with feeding, hunger and satiety.    
 
The mRNA concentration of NPY showed no significant differences between the different 
samplings in all parts of the brain except in the midbrain between the second sampling 
(November 19th) and the last sampling (November 30th) (Figure 3.8). The fish from the 
second sampling had been starved for 3 days and the fish from the last sampling was recently 
fed. Since NPY is assumed to be an orexigenic neuropeptide, this will naturally decrease as 
feeding occurs in fish. This could be a reason for the mRNA expression to be significantly 
lower in the last sampling than in the second sampling. The difference is however in the 
midbrain, not a tissue normally identified with feed regulation. This might suggest other 
properties of the NPY in the midbrain of the salmon, that is influenced by starvation and 
feeding. It could also indicate that midbrain of Atlantic salmon is involved in appetite 
regulation previously not described.  
 
4.3.2 Spatial and temporal changes in CART  
CART was first discovered in rats in 1995 and it is a potent anorexigenic neuropeptide in 
mammals as well as in fish. Multiple CART variants have been described for a variety of 
different animals and fish species, but only one CART has been described in Atlantic salmon. 
This CART isoform will be the focus for this thesis (Valassi et al., 2008, Murashita et al., 
2009, Kehoe and Volkoff, 2007, Valen et al., 2011).  
In Atlantic salmon fasting for 6 days decreases the mRNA expression of CART in the brain 
which suggest an anorexigenic effect in salmon. CART regulates both the short-term and 
long-term feeding and plays a role in central control of the body weight (Valen et al., 2011). 
The involvement of CART in food regulation is also believed to be in the ARC in the 




eye, which suggests other properties for CART in addition to signaling an anorexigenic effect 
(Murashita et al., 2009). For cod larvae CART has been suggested to play a role in olfactory 
and visual processes as well as appetite regulation (Le et al., 2016).   
In this experiment mRNA expression in the forebrain was significantly (p<0.05) higher than 
in the cerebellum and in the pituitary (Figure 3.4). There was no significant difference 
between the forebrain and the other parts of the brain. Between midbrain, cerebellum, 
hypothalamus, Saccus vasculosus and the pituitary there was no significant difference in 
mRNA expression of CART. Hypothalamus showed a higher (4.38 and 18.25 times 
respectively) mRNA concentration than in the cerebellum and the pituitary, however this was 
not a significant difference.  
 
No significant difference in mRNA expression was observed between the different samplings 
in any of the brain tissues. From previously mentioned studies (Murashita et al., 2009), the 
levels of mRNA expression in the whole brain decreased with fasting for multiple days, 
however this was not observed in this experiment. There are a few possible reasons to why the 
mRNA expression of CART did not show a significant difference during this experiment. The 
first reason could be the low sampling size in the different samplings (n=3-6), which causes 
an uncertainty of the results, were one fish can affect the result in both positive and negative 
terms. Another explanation of the undifferentiated CART expression could be the 
experimental design. Fasting has shown a decrease in the expressed levels of CART, however 
stress has been shown to reduce the appetite of Atlantic salmon (as well as other species) 
(Madaro et al., 2015, Bernier, 2006). CART stimulates CRF (Corticotropin releasing factor) 
secretion which in turn is a hormone associated with a stress response in salmon as well as 
other species. Stress regulates the CART mRNA expression in the hypothalamus which works 
in contrast to the previous mentioned effect of a decrease in CART expression during fasting 
(Koylu et al., 2006). Therefore, it may be two opposite effects taking place during this 
experiment which makes these results hard to interpret.  
 
4.3.3 Spatial and temporal changes in AgRP-1  
AGRP coupled with NPY are strong orexigenic factors in the ARC are the main inducers of 




Melanocortin-4-receptor (MC4R) and α-melanocyte-stimulating hormone (α-MSH) in rodents 
(Harrold et al., 1999, Rønnestad et al., 2017, Ollmann et al., 1997).  
In a study done on rats including a control group, a dietary-obese group and a food-restricted 
group, the obese group showed a significant increase in of AgRP concentration and the 
restricted group showed a significant decrease in AgRP concentration (Harrold et al., 1999). 
This further confirms the role of AgRP as a potent orexigenic neuropeptide. In Atlantic 
salmon two different forms of AgRP has been discovered; AgRP-1 and AgRP-2. AgRP-1 is 
mainly expressed in the pituitary as well as the skin, but also in different tissues like the brain 
ovaries and the eyes. AgRP-1 is also present in the female gonads (not in males) which 
suggests a gender difference in other functions than the orexigenic factor. AgRP-2 was 
present and expressed in all tissues examined. This is an indicator of AgRP-1 and AgRP-2 has 
different roles in Atlantic salmon (Murashita et al., 2009).  
 
In this experiment the mRNA expression of AgRP-1 showed no significant differences 
between the different tissues in the brain (Figure 3.5). The expressed levels of AgRP-1 in 
hypothalamus, Saccus vasculosus and the pituitary is around the same levels (72.1, 75.8 and 
86.0 times the concentration of the midbrain respectively), but these differences are not 
significant, and no conclusion can be drawn from this experiment to which tissues contains 
the highest concentration of AgRP-1.  
 
For the second part of this experiment AgRP-1 showed no significant differences between any 
of the different samplings in the different tissues. Murashita et al., 2009 showed a decrease in 
mRNA expression for AgRP-1 during 6 days of fasting for the whole brain. This experiment 
could not replicate these results, most likely due to differences in analysis of whole and 
dissected brains, the previously mentioned sample size and the experimental design with both 
fasting and stress from vaccination simultaneously.  
 
4.3.4 Spatial and temporal changes in POMCa2s  
POMC is a group of potent anorexigenic peptides and has been described in many different 
groups of animals, including mammals and fish. Cleavage products from POMC includes α- 




(Valassi et al., 2008, Klovins et al., 2004). POMC are also involved in other physiological 
functions such as stress response, steroid synthesis and lipolysis (Murashita et al., 2011). In 
the Atlantic salmon four different isoforms of POMC has been identified (-a1, -a2, -a2s and -
b). During an experiment with fasting for 6 days only POMCa1 showed a significant 
difference (p<0.05) in mRNA expression (Murashita et al., 2009). This could be an indication 
of a stronger anorexigenic effect in POMCa1 than the three other isoforms. This experiment 
will however be focusing on POMCa2s.  
 
For the first part of this experiment the mRNA expression of POMCa2s in the different brain 
tissues was examined. The pituitary showed a significant higher mRNA expression of 
POMCa2s than the other tissues in the brain. Hypothalamus and Saccus vasculosus showed a 
higher concentration of POMCa2s than forebrain, midbrain and cerebellum, however there 
was no significant difference between any of these tissues (Figure 3.6). Even though the ARC 
located in the hypothalamus is the primary area involved in regulation of feed intake (Valassi 
et al., 2008, Rønnestad et al., 2017), the mRNA expression in this tissue is much lower than in 
the pituitary (0.13%). This either suggest a feed regulation for POMCa2s in the pituitary or 
another function of POMCa2s expressed in the pituitary. In Coho salmon POMC-related 
peptides is produced in pars intermedia in the pituitary (a region between the anterior- and the 
posterior pituitary) (Rand-Weaver et al., 1992). Because of the close relationship between 
Atlantic salmon and Coho salmon (both parts of the subfamily Salmonidae) an assumption 
can be made that Atlantic salmon also produces POMC in the pars intermedia in the pituitary.  
 
The mRNA expression in midbrain, cerebellum, hypothalamus, Saccus vasculosus and 
pituitary showed no significant difference between the samplings. In the forebrain there was a 
significant difference from the first sampling to all the other samplings. From a previous 
study, no significant difference in mRNA expression of POMCa2s was observed from 3hpf to 
24hpf in the brain (Valen et al., 2011). The study analyzed the whole brain and did not divide 
the brain into different parts. This experiment divided the brain and the expression of 
POMCa2s in the forebrain only contained 0.05% of the concentration in the pituitary. This 
could be a reason no significant difference was observed during the other experiment which 
used the whole brain, however a significant difference in the forebrain could be observed for 





In conclusion this experiment showed that all the four neuropeptides believed to be key 
players in appetite control of Atlantic salmon are expressed in the hypothalamus, but also to a 
very variable degree in other parts of the brain. There was a significant difference in mRNA 
expression between the different brain tissues for three of the four studied neuropeptides 
(NPY, CART and POMCa2s). However, for AgRP-1 there was no significant differences, 
even though there was a tendency for a higher concentration in hypothalamus, Saccus 
vasculosus and pituitary than the forebrain, midbrain and cerebellum. 
Between the samplings during this experiment, the only significant difference observed was in 
the forebrain for POMCa2s (between the first sampling and all the others) and NPY in the 
midbrain (between the second and the last sampling). Whether the observed difference here is 
from the starvation or the stress cannot be stated with certainty. Based on these results the 
H01a, b, c, d can be rejected, however the H02 cannot be rejected as there were little significant 
differences in mRNA concentration between the different parts of the brain during this 
experiment. If e.g. an increase in mRNA expression for NPY occurs in the hypothalamus it 
might not be a significant increase due to the high concentration of NPY in the forebrain if the 
brain is analyzed as a whole. For further studies on the appetite control in Atlantic salmon, 
dissection of the brain is therefore recommended to be able to distinguish in which tissues the 
appetite regulation take place. This could also further the knowledge of other roles of the 
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Table 1. Test results from a one-way ANOVA on mRNA expression for sampling 1 
(November 16th) for NPY. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 3.715524 1 3.715524 49.30206 0.000014 
Gr 6.112261 5 1.222452 16.22097 0.000056 
Error 0.904349 12 0.075362     
 
Table 2. Test results from a one-way ANOVA on mRNA expression for sampling 1 
(November 16th) for CART.  
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 24.39542 1 24.39542 57.58610 0.000006 
Gr 11.56579 5 2.31316 5.46028 0.007544 
Error 5.08360 12 0.42363     
 
Table 3. Test results from a one-way ANOVA on mRNA expression for sampling 1 
(November 16th) for AgRP-1. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.010475 1 0.010475 6.118759 0.029299 
Gr 0.008341 5 0.001668 0.974437 0.471416 






Table 4. Test results from a one-way ANOVA on mRNA expression for sampling 1 
(November 16th) for POMCa2s.  
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 19.62781 1 19.62781 4.285424 0.060674 
Gr 97.36960 5 19.47392 4.251826 0.018599 
Error 54.96157 12 4.58013     
 
Table 5. Test results from a one-way ANOVA on mRNA expression between samplings for 
NPY in forebrain.  
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 90.27248 1 90.27248 80.42889 0.000000 
NPY 4.34537 6 0.72423 0.64526 0.693324 
Error 26.93730 24 1.12239     
 
Table 6. Test results from a one-way ANOVA on mRNA expression between samplings for 
NPY in midbrain. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 6.468116 1 6.468116 284.7343 0.000000 
NPY 0.372825 6 0.062137 2.7354 0.036067 
Error 0.545192 24 0.022716     
 
Table 7. Test results from a one-way ANOVA on mRNA expression between samplings for 
NPY in cerebellum.  
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.083500 1 0.083500 10.21401 0.003879 
NPY 0.070184 6 0.011697 1.43085 0.244054 





Table 8. Test results from a one-way ANOVA on mRNA expression between samplings for 
NPY in hypothalamus.  
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.625607 1 0.625607 90.29484 0.000000 
NPY 0.069297 6 0.011549 1.66695 0.172502 
Error 0.166284 24 0.006928     
 
Table 9. Test results from a one-way ANOVA on mRNA expression between samplings for 
NPY in Saccus vasculosus.  
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 1.252887 1 1.252887 153.1362 0.000000 
NPY 0.132619 6 0.022103 2.7016 0.037850 
Error 0.196356 24 0.008182     
 
Table 10. Test results from a one-way ANOVA on mRNA expression for between samplings 
for NPY in pituitary. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.009872 1 0.009872 148.4911 0.000000 
NPY 0.000385 6 0.000064 0.9642 0.469946 






Table 11. Test results from a one-way ANOVA on mRNA expression between samplings for 
CART in forebrain. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 265.5782 1 265.5782 291.2552 0.000000 
NPY 10.1370 6 1.6895 1.8528 0.130988 
Error 21.8842 24 0.9118     
 
Table 12. Test results from a one-way ANOVA on mRNA expression between samplings for 
CART in midbrain. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 24.24030 1 24.24030 293.4843 0.000000 
NPY 1.11022 6 0.18504 2.2403 0.073906 
Error 1.98228 24 0.08259     
 
Table 13. Test results from a one-way ANOVA on mRNA expression between samplings for 
CART in cerebellum. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 4.600418 1 4.600418 81.98073 0.000000 
NPY 0.415060 6 0.069177 1.23275 0.324667 
Error 1.346780 24 0.056116     
 
Table 14. Test results from a one-way ANOVA on mRNA expression between samplings for 
CART in hypothalamus. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 28.84457 1 28.84457 147.5717 0.000000 
NPY 1.74573 6 0.29096 1.4886 0.224320 





Table 15. Test results from a one-way ANOVA on mRNA expression between samplings for 
CART in Saccus vasculosus. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 40.69751 1 40.69751 330.1366 0.000000 
NPY 1.21917 6 0.20319 1.6483 0.177321 
Error 2.95859 24 0.12327     
 
Table 16. Test results from a one-way ANOVA on mRNA expression between samplings for 
CART in pituitary. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.166170 1 0.166170 285.5864 0.000000 
NPY 0.004961 6 0.000827 1.4211 0.247562 
Error 0.013965 24 0.000582     
 
Table 17. Test results from a one-way ANOVA on mRNA expression between samplings for 
AgRP-1 in forebrain. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.000050 1 0.000050 4.195356 0.051625 
NPY 0.000123 6 0.000020 1.722032 0.159002 






Table 18. Test results from a one-way ANOVA on mRNA expression between samplings for 
AgRP-1 in midbrain.  
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.000017 1 0.000017 15.42632 0.000633 
NPY 0.000007 6 0.000001 1.15258 0.363500 
Error 0.000026 24 0.000001     
 
Table 19. Test results from a one-way ANOVA on mRNA expression between samplings for 
AgRP-1 in cerebellum. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.000023 1 0.000023 115.9783 0.000000 
NPY 0.000001 6 0.000000 0.9373 0.486863 
Error 0.000005 24 0.000000     
 
Table 20. Test results from a one-way ANOVA on mRNA expression between samplings for 
AgRP-1 in hypothalamus.  
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.090893 1 0.090893 26.28885 0.000030 
NPY 0.011239 6 0.001873 0.54179 0.771211 
Error 0.082980 24 0.003457     
 
Table 21. Test results from a one-way ANOVA on mRNA expression between samplings for 
AgRP-1 in Saccus vasculosus. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 4.613143 1 4.613143 19.10248 0.000206 
NPY 1.674008 6 0.279001 1.15531 0.362113 




Table 22. Test results from a one-way ANOVA on mRNA expression between samplings for 
AgRP-1 in pituitary.  
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.559537 1 0.559537 81.38450 0.000000 
NPY 0.103167 6 0.017195 2.50094 0.050528 
Error 0.165006 24 0.006875     
 
Table 23. Test results from a one-way ANOVA on mRNA expression between samplings for 
POMCa2s in forebrain. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.000033 1 0.000033 32.16641 0.000008 
NPY 0.000016 6 0.000003 2.66907 0.039655 
Error 0.000024 24 0.000001     
 
Table 24. Test results from a one-way ANOVA on mRNA expression between samplings for 
POMCa2s in midbrain. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.000481 1 0.000481 2.204521 0.150624 
NPY 0.001550 6 0.000258 1.185349 0.347170 
Error 0.005232 24 0.000218     
 
Table 25. Test results from a one-way ANOVA on mRNA expression between samplings for 
POMCa2s in cerebellum. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.000013 1 0.000013 80.67433 0.000000 
NPY 0.000001 6 0.000000 1.17516 0.352181 





Table 26. Test results from a one-way ANOVA on mRNA expression between samplings for 
POMCa2s in hypothalamus. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.002463 1 0.002463 23.54679 0.000060 
NPY 0.000440 6 0.000073 0.70078 0.651700 
Error 0.002511 24 0.000105     
 
Table 27. Test results from a one-way ANOVA on mRNA expression between samplings for 
POMCa2s in Saccus vasculosus. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 0.002684 1 0.002684 26.16421 0.000031 
NPY 0.001227 6 0.000204 1.99270 0.106477 
Error 0.002462 24 0.000103     
 
Table 28. Test results from a one-way ANOVA on mRNA expression between samplings for 
POMCa2s in pituitary. 
Effect  
SS Degr. of 
Freedom 
MS F p 
Intercept 2938.768 1 2938.768 61.17245 0.000000 
NPY 251.509 6 41.918 0.87256 0.529301 






Table 29. Test results from a post-hoc test (Newman-Keuls test) on mRNA expression 
between different tissues for NPY during sampling 1 (November 16th).  
Cell no. 
Gr {1}         
1,7119 
{2}         
0,47413 
{3}         
0.04902 
{4}         
0.17604 
{5}         
0.29467 
{6}         
0.02026 
1 Forebrain   0.000284 0.000203 0.000273 0.000278 0.000218 
2 Midbrain 0.000284   0.279908 0.406527 0.439086 0.311605 
3 Cerebellum 0.000203 0.279908   0.581513 0.534510 0.900167 
4 Hypothalamus 0.000273 0.406527 0.581513   0.606455 0.770938 
5 
Saccus 
vasculosus 0.000278 0.439086 0.534510 0.606455   0.624283 
6 Pituitary 0.000218 0.311605 0.900167 0.770938 0.624283   
 
Table 30. Test results from a post-hoc test (Newman-Keuls test) on mRNA expression 
between different tissues for CART during sampling 1 (November 16th).  
Cell no. 
Gr {1}         
2.4867 
{2}         
0.98718 
{3}         
0.36449 
{4}         
1.5955 
{5}         
1.4637 
{6}         
0.08739 
1 Forebrain   0.064459 0.012665 0.119512 0.174155 0.007236 
2 Midbrain 0.064459   0.264185 0.506566 0.387698 0.247654 
3 Cerebellum 0.012665 0.264185   0.148729 0.138554 0.611710 
4 Hypothalamus 0.119512 0.506566 0.148729   0.808490 0.089949 
5 
Saccus 
vasculosus 0.174155 0.387698 0.138554 0.808490   0.095311 






Table 31. Test results from a post-hoc test (Newman-Keuls test) on mRNA expression 
between different tissues for POMCa2s during sampling 1 (November 16th).  
Cell no. 
Gr {1}         
0.00308 
{2}         
0.00111 
{3}         
0.00098 
{4}         
0.00841 
{5}         
0.00692 
{6}         
6.2449 
1 Forebrain   0.999225 0.999999 0.999995 0.998375 0.017548 
2 Midbrain 0.999225   0.999950 1.000000 0.999995 0.025946 
3 Cerebellum 0.999999 0.999950   1.000000 1.000000 0.034945 
4 Hypothalamus 0.999995 1.000000 1.000000   0.999444 0.004013 
5 Saccus vasculosus 0.998375 0.999995 1.000000 0.999444   0.010098 




Table 32. Test results from a post-hoc test (Newman-Keuls test) on mRNA expression 
between different samplings for NPY in midbrain. 
Error: Between MS = 0.22272, df = 24.000 
Cell 
no. 
NPY {1}         
0.47413 
{2}         
0.66754 
{3}         
0.41061 
{4}         
0.43028 
{5}         
0.56634 
{6}         
0.42902 
{7}         
0.29894  
1 1   0.200273 0.926741 0.675641 0.381916 0.901031 0.456849  
2 2 0.200273   0.200731 0.153090 0.387091 0.210830 0.028645  
3 3 0.926741 0.200731   0.980378 0.569378 0.860403 0.291432  
4 4 0.675641 0.153090 0.980378   0.401008 0.990472 0.590676  
5 5 0.381916 0.387091 0.569378 0.401008   0.555470 0.140149  
6 6 0.901031 0.210830 0.860403 0.990472 0.555470   0.432564  






Table 33. Test results from a post-hoc test (Newman-Keuls test) on mRNA expression 
between different samplings for NPY in Saccus vasculosus. 
Error: Between MS = 0.00818, df = 24.000 
Cell 
no. 
NPY {1}         
0.29467 
{2}         
0.28158 
{3}         
0.21296 
{4}         
0.13193 
{5}         
0.25242 
{6}         
0.14153 
{7}         
0.12270 
1 1   0.834956 0.562400 0.130814 0.777188 0.132442 0.123948 
2 2 0.834956   0.520509 0.147139 0.643094 0.137353 0.147064 
3 3 0.562400 0.520509   0.406392 0.531357 0.261536 0.480027 
4 4 0.130814 0.147139 0.406392   0.238615 0.878523 0.883160 
5 5 0.777188 0.643094 0.531357 0.238615   0.195853 0.257314 
6 6 0.132442 0.137353 0.261536 0.878523 0.195853   0.950751 




Table 34. Test results from a post-hoc test (Newman-Keuls test) on mRNA expression 
between different samplings for POMCa2s in forebrain. 
Error: Between MS = 0.00000, df = 24.000 
Cell 
no. 
NPY {1}         
0.00308 
{2}         
0.00088 
{3}         
0.00079 
{4}         
0.00048 
{5}         
0.00093 
{6}         
0.00073 
{7}         
0.00044 
1 1   0.010624 0.014028 0.010660 0.004839 0.017812 0.012571 
2 2 0.010624   0.893175 0.936111 0.941842 0.974191 0.968312 
3 3 0.014028 0.893175   0.895904 0.976155 0.935141 0.959156 
4 4 0.010660 0.936111 0.895904   0.963571 0.718121 0.961656 
5 5 0.004829 0.941842 0.976155 0.963571   0.991174 0.979408 
6 6 0.017812 0.974191 0.935141 0.718121 0.991174   0.910220 







Table 35. Temperature (oC), CO2 (mg L
-1), NO2 (mg L
-1), NH4 (mg L
-1) and NO3 (mg L
-1) 
during the experiment. Data provided by Hardingsmolt.   
  16/11 17/11 18/11 19/11 20/11 21/11 
Temperature °C 13.1 12.9 12.0 12.8 13.2 13.3 
CO2 mg L
-1 NA 7 NA NA 0.5 NA 
NO2 mg L
-1 NA 0.096 NA NA 0.12 NA 
NH4 mg L
-1 NA 0.05 NA NA 0.11 NA 
NO3 mg L
-1 NA 250 NA NA 250- NA 
 22/11 23/11 24/11 25/11 26/11 27/11 
Temperature °C 13.3 13.5 13.1 12.8 13.2 13.5 
CO2 mg L
-1 3 NA 8 NA NA 10 
NO2 mg L
-1 0.115 NA 0.175 NA NA 0.180 
NH4 mg L
-1 0.02 NA 0.015 NA NA 0.13 
NO3 mg L
-1 250- NA 100+ NA NA 250 
 28/11 29/11 30/11    
Temperature °C 13.7 12.9 13.4    
CO2 mg L
-1 NA 11 NA    
NO2 mg L
-1 NA 0.470 NA    
NH4 mg L
-1 NA 0.1 NA    
NO3 mg L
-1 NA 250 NA    
 
